Background. The recommended parameter of dialysis dose differs between K-DOQI and the European Best Practice Guidelines. It is not well known to what extent an agreement exists between the different parameters, nor if target and delivered dialysis dose are prescribed according to the urea reduction rate (URR), single-pool Kt/V (spKt/V) or equilibrated double-pool Kt/V (eKt/V) and which parameter is most strongly related to mortality. Methods. In 830 haemodialysis patients from the NECO-SAD cohort URR, spKt/V and eKt/V were calculated and compared according to a classification regarding the recommended treatment targets (70%, 1.4 and 1.2, respectively) as well as minimum delivered dialysis dose (65%, 1.2 and 1.05, respectively). Moreover, the relation between treatment dose and survival was assessed using Cox regression analysis. Results. A spKt/V of !1.4 and URR !70% corresponded with eKt/V !1.20 (as reference method) in, respectively, 98.0 and 90.6% of patients. spKt/V of !1.2 and URR !65% corresponded with eKt/V !1.05 in, respectively, 95.5 and 91.2% of patients. Deviations from the reference method were significantly related to differences in urea distribution volume (spKt/V), treatment time (URR) and ultrafiltration volume (URR). The adjusted HR (95% CI) was 0.98 (0.96, 0.99) for URR, 0.51 (0.31, 0.84) for spKt/V and 0. 46 (0.30, 0.80) for the eKt/V. Conclusion. The use of URR leads to larger disagreement with the reference method (eKt/V) treatment target as compared to spKt/V. Low urea distribution volume, short treatment time and low ultrafiltration volumes are predictive parameters for overestimation of dialysis dose when utilizing the alternative methods spKt/V and URR instead of eKt/ V. Delivered eKt/V, spKt/V and URR were all positively related to survival.
Introduction
The delivered haemodialysis treatment dose is an important prognostic factor in patients treated with haemodialysis [1] . In addition, a survey of the medical literature reported an increase in the quality-adjusted life expectancy of haemodialysis patients with increasing dialysis adequacy [2] .
To determine dialysis adequacy, various methods are currently used. The most simple marker is the urea reduction rate (URR) for which only the pre-and post-dialytic blood urea concentrations are needed. However, the use of URR does not take the effects of ultrafiltration on urea removal into account nor the effect of urea generation during dialysis. These factors are integrated when the formula of single-pool Kt/V urea (spKt/V) is used to assess dialysis adequacy. The calculation of spKt/V is somewhat more elaborate, as data of body weight, type of vascular access, treatment time and ultrafiltration volume are needed. However, with spKt/V, the effect of urea rebound from the peripheral tissues to the blood is neglected. For this purpose, the formula of equilibrated double-pool Kt/V (eKt/V) was developed, which corresponds to spKt/V with 30-min urea rebound. For computation of eKt/V, no additional parameters in addition to those needed for calculation of spKt/V are required, although the formula is slightly more complicated compared to spKt/V.
Various guidelines groups have defined targets for dialysis dose prescription [3, 4] . The Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines recommend measurements of haemodialysis dose using spKt/V, whereas the European Best Practice Guidelines (EBPG) prefer using eKt/ V [3, 4] .
In addition, some national registries, such as the United Kingdom Renal Registry [5] , advocate the use of URR to assess dialysis adequacy. However, although the EBPG on dialysis adequacy have been published various years ago, a recent survey by the EDTA-QUEST [6] initiative showed that URR (46%), followed by spKt/V (35%), was used in the great majority of dialysis centres in daily practice. eKt/ V was used by only 13% of respondents.
The primary aim of our study was to determine the agreement between URR, spKt/V and eKt/V in the assessment of dialysis adequacy, taking the different cutoff values for these parameters into account. Secondly, to determine factors for disagreement, considering eKt/V as the reference method. Thirdly, the relation to survival in URR, spKt/V and eKt/V was assessed.
Materials and methods

Patients
Patients with end-stage renal disease starting dialysis treatment in 38 dialysis centres in The Netherlands were invited to participate in the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD) study. The recruitment of patients was between August 1996 and March 2007. Inclusion criteria were aged >18 years and starting renal replacement therapy for the first time. Additional criteria for the present analysis were treatment with haemodialysis (n ¼ 1122) and complete data for the measurement of dialysis adequacy at 12 months after the start of dialysis (n ¼ 830). The other patients had died (148), were excluded (105) or had insufficient data for Kt/V analysis (39). The study was approved by the Medical Ethics Committees of all participating hospitals. All patients gave written informed consent.
Design
At the start of dialysis, data regarding clinical and demographic characteristics, including gender, age, smoking status, primary kidney disease and comorbidity, were collected. Patients were followed at 3 and 6 months after the start of dialysis treatment, thereafter at 6-month intervals. Data for dialysis adequacy were collected at 12 months after the start of dialysis because stability in haemodialysis treatment may be assumed and the contribution of residual renal function may be less prominent as compared to the 3 and 6 months data. Body weight was measured before and after each haemodialysis session. Treatment characteristics collected were dialysis frequency, ultrafiltration volume and treatment time. Blood samples were drawn before and after a monitoring dialysis session and again before the following dialysis session. Urine was collected during the entire interdialytic interval. Follow-up was until time of death, transplantation, transfer to a non-participating hospital, recovery of renal function or end of study (20 August 2007). Follow-up was censored to a maximum of 5 years.
Data collection
Demographic and baseline data were obtained 0-4 weeks before the start of chronic dialysis treatment. Co-morbidities were scored in the case of presence of a doctor's diagnosis. Co-morbidity risk score was assessed as recommended by Khan et al. [7] . Primary kidney disease and cause of death were classified according to the codes of the European Renal AssociationDialysis and Transplantation Association [8] .
Dialysis dose/adequacy eKt/V was computed using the Daugirdas-Schneditz rate equation (Equation 1 in Appendix) and considered as reference method, while spKtV and URR were determined from the pre-and post-dialysis blood urea nitrogen (BUN) using the two BUN method (Equations 2 and 3 in Appendix). Urea distribution volume (V) was calculated using Watson's formula (Equation 5 in Appendix). rGFR was estimated according to the formula in Equation 6 (Appendix). Since residual renal function may contribute significantly to final weekly Kt/V, the estimation of renal plus dialytic Kt/V allows better judgement of total adequacy. Therefore, rKt/V 1 eKt/V (week) and rKt/V 1 spKt/V (week) were also assessed. eKt/V and spKt/V including rGFR were expressed in weekly rKt/V 1 eKt/V (week) and subsequently rKt/V 1 spKt/ V (week) (Equation 7 in Appendix) to value total treatment dose. Especially standardized Kt/V (stdKt/V) is designed to compare dialysis treatments with different dialysis schedules on adequacy. Therefore, stdKt/V including renal stdKt/V was additioned to provide an overall marker in the dialysis adequacy according to the formula in appendix 4.
Minimal dialysis adequacy was compared between the minimum aims: eKt/V > 1.05, which is the mimimum according to the HEMO study [9, 10] and to spKt/V >1.2 and URR >65% (mimimum according to K-DOQI) [3] .
The target dialysis adequacy was compared between the target levels of the different methods: eKt/V > 1.20 (target EBPG 2001), spKt/V >1.40 and URR >70% (target K-DOQI).
The Dialysis adequacy was also categorized in order to enable comparison between the different adequacy formulas with different units. This was achieved by classifying into three categories. The middle category of each of the dialysis adequacy formulas, considered as sufficient dialysis dose and defined as the reference group, was compared to the lowest category (inadequate dialysis) and the highest category (above target dose).
Statistical analysis
Results are expressed as mean AE SD. Differences in continuous variables were tested using the Students t-test if normally distributed or Wilcoxon rank-sum test if skewed. The agreement between the different methods was analysed using linear and quadratic regression models and descriptive statistics. Crude and adjusted hazard ratios (HRs) for the different parameters were calculated using Cox proportional hazards regression modelling. In analogy to the study of Termorshuizen et al. [11] age, Khan co-morbidity score, primary kidney disease and body mass index were used as covariates.
The sensitivity was defined as the number of true-positive minimal haemodialysis adequacy divided by the sum of true-positive and falsenegative haemodialysis adequacy; specificity was defined as the number of true-negative haemodialysis adequacy divided by the sum of false-positive and true-negative haemodialysis adequacy; positive predictive value (PPV) was defined as the number of true-positive divided by the sum of true-positive and false-positive minimal haemodialysis adequacy; The Negative predictive value (NPV) was defined as the number of true-negative divided by the sum of true-negative and false-negative minimal haemodialysis adequacy; and accuracy was defined as the sum of true-positive and true-negative results divided by the total number of estimations performed.
The SPSS-13.0 package was used for statistical analysis. P 0.05 was regarded as statistically significant.
Results
A total of 2062 patients were included in the NECOSAD study. About 1217 patients started with haemodialysis. In 830 of those, data for dialysis adequacy assessment at 12 months after the start of dialysis were available and were included in the present analysis.
Baseline characteristics of these patients are listed in Table 1 . At 12 months after start of dialysis, the mean age was 64, 41% was female, 21% had diabetes and 74% of the haemodialysis patients were treated three times per week or more. Mean haemodialysis treatment time was 10.29 AE 1.97 h/week. In Table 2 , the characteristics of haemodialysis treatment, haemodialysis adequacy and renal urea clearance (rGFR) are shown. Residual renal function was present in 522 patients.
Adequacy of haemodialysis dose
Twelve months after start of dialysis, mean delivered eKt/V was 1.02 AE 0.23, spKtV 1.18 AE 0.26 and URR 63 AE 8%. Mean rGFR was 3.69 AE 1.9 mL/min and mean V was 37.2 AE 6.3 litres. Taking rGFR into account, total mean rKt/V 1 eKt/V (week) was 3.56 AE 0.86 and mean rKt/V 1 spKt/V (week) 3.99 AE 0.96. Total mean stdKt/V 1 renals stdKt/V was (>2.1) [3] in 67.5% of the patients ( Table 2) .
Comparison of dialysis adequacy measures
The correlation between spKt/V and eKt/V (Pearson correlation r ¼ 0.99, P < 0.001) and URR and eKt/V (Pearson correlation r ¼ 0.95, P < 0.001) was highly significant (Figure 1) .
When spKt/V was used, 374 patients reached the minimum dose, whereas in 17 (4%) of those the minimum eKt/V was not attained ( Figure 1A) . When using the URR equation, in 352 patients, dialysis dose attained the minimum criteria, whereas eKt/V showed in 31 (9%) of these patients an inadequate dialysis dose ( Figure 1B) .
Using eKt/V !1.2, spKt/V !1.4 and URR !70% as target aims for adequate haemodialysis dose, the three different parameters were analysed. In 161 (19%) of the patients, spKt/V dialysis dose was at or above the target range, without taking into account residual renal function. However, three of these patients (2%) did not reach the target level according to eKt/V (<1.2 but >1.19) ( Figure 1C ). When URR was used in the cohort of 830 patients, 160 (19%) patients had a dialysis dose at or above the target range. In fifteen of those (9%), eKt/V was below the target (<1.2 but !1.08) ( Figure 1D ).
In Figure 2 , sensitivity, specificity, PPV and NPV from the different parameters are shown. Table 3 summarizes differences in characteristics of patients in which the dialysis adequacy would be overestimated when alternative methods for estimating dialysis adequacy were used instead of the reference method. Treatment time and ultrafiltration volume were significantly different at the misclassification when the minimum dose of URR was reached instead of eKt/V [8.8 versus 10.2 h/week, respectively, 571 versus 1993 mL/treatment; P < 0.05)]. The misclassification using spKt/V instead of eKt/V as minimum cutoff point showed significant differences in treatment time (9.3 versus 10.4 h/week; P < 0.05) and urea distribution volume (31.1 versus 34.8 l; P < 0.05). The disagreement of reaching target dose by the alternative parameters compared to the reference method showed the same significant characteristics. Treatment time and ultrafiltration volume were significantly different between the classified and misclassified patients when URR was used to judge sufficient dialysis dose instead of eKt/V (8.2 versus 10.2 h/week for treatment time and 330 versus 1916 mL/ treatment for ultrafiltration; P < 0.05). When using spKt/V instead of eKt/V, only urea distribution volume obtained statistical significance while defining characteristics of misclassified patients (28.8 versus 33.3 l; P < 0.05).
Relation of the different treatment indices with mortality
URR, spKt/V and eKt/V were each significantly related to survival, after correction for confounding factors. For each unit increase in dialysis adequacy, the adjusted HR (95% CI) was 0.98 (0.96, 0.99) for URR, 0.51 (0.31, 0.84) for spKt/V and 0.46 (0.30, 0.80) for eKt/V. It should be noted that the units and range of the different methods for assessment of dialysis adequacy are different and cannot be compared amongst each other. When dividing the groups into three categories (below minimum, above target and levels between minimum and target), with the latter as reference, the trends in survival between the different parameters remained, but only reached significance for eKt/V. Patients with eKt/V levels in the lowest category (below minimum) had the highest risk of mortality independent of other factors (Table 4) .
Discussion
The results of the present study show that minimum dialysis dose is satisfactory predicted by spKt/V and URR in a majority of patients (96 and 91%, respectively), considering eKt/V as reference method. In a minority of patients, the adequacy minimum for eKt/V was not met, despite the fact that URR and/or spKt/V appeared to be in an acceptable range. The risk of misclassification was higher for URR (9%) compared to spKt/V (4%). All adequacy parameters were significantly related to mortality. However, after categorizing patients according to minimum and target values of the different adequacy parameters, only for eKt/V mortality rates were higher when minimum levels were not met.
There has been ample discussion about the recommended parameter for dialysis dose in various guidelines [3, 4] . Whereas the EBPG recommends the use of eKt/V as the parameter of dialysis dose, spKt/V is advocated by K-DOQI. The rationale for the use of eKt/V by EBPG is based on the fact that urea rebound after dialysis is taken into account by adding a time-dependent factor to the equation (12) . Especially in patients treated with very short dialysis sessions, the difference between spKt/V and eKt/V increases, which might result in overestimating dialysis adequacy when dialysis dose is valued by spKt/V [2] . In contrast, the K-DOQI group decided to maintain spKt/V as the recommended parameter of dialysis dose, as shortened dialysis treatment times are not allowed by both K-DOQI and EBPG guidelines and because eKt/V is a mathematical derivative of spKt/V, which cannot be adjusted directly by changing treatment parameters [3] . In our study, in only 4% of patients with a spKt/V !1.2, eKt/V was < 1.05. Moreover, we see in this 'misclassified' subgroup, a mean eKt/V of 1.03 (<1.05 but >1.01), which is very close to minimum level. The notion that ultrashort C2= the percentage of overestimating hemodialysis adequacy when using the alternative method PPV= positive predictive value NPV= negative predictive value Fig. 2 . Threshold values for minimal haemodialysis adequacy when using alternative methods instead of eKt/V. C2, the percentage of overestimating haemodialysis adequacy when using the alternative method; PPV, positive predictive value; NPV, negative predictive value. Agreement between different parameters of dialysis dose dialysis neither was nor is current practice in the Netherlands [12] , explains our observation that the great majority of patients with spKt/V values >1.2 had eKt/V levels >1.05, whereas in those patients who were misclassified according to spKt/V, the difference with the eKt/V target was very small. For calculation of URR, only pre-and post-dialytic urea measurements are needed. Therefore it is a simple and timesaving calculated index [13, 14] . However, weight of the patient, ultrafiltration volume and treatment time are not taken into account in this formula and therefore deviations from the reference method parameter may be assumed. Especially at higher levels of URR, the discrepancy with Kt/V was found to increase in previous studies [15, 16] . Nevertheless, in the present study, the correlation was highly significant, but its linearity became exponential for eKt/V >1.3. Nine percent of patients with a URR above minimum (65%) had eKt/V <1.05 (<1.05 but !0.93). Mean eKt/V in these patients was 0.99. Differences in dialysis parameters, which were related to misclassification when URR is used instead of eKt/V to express target or minimum achieved dose, were sex, treatment time and ultrafiltration volume. For the spKt/V formula, treatment time (<10 h a week) and urea distribution volume were lower in those patients who were above the minimum dose according to spKt/V but below the minimum dose according to eKt/V. At low urea distribution volumes and short treatment time, a larger rebound effect will be expected, which might explain the discrepancy between URR and spKt/V with eKt/V. The relation between misclassification according to URR and ultrafiltration volume can be explained by the notion that convective urea clearance, which is related to ultrafiltration volume, is not taken into account when using URR [17] .
In agreement with previous studies [13, [18] [19] [20] [21] [22] [23] [24] , we found that eKt/V, spKt/V and URR were significantly related to survival. When analysing the minimum cutoff values, only eKt/V below these values predicted mortality significantly with a similar trend for spKt/V below minimum. Moreover, as differences in HRs between the respective formulas were small, the results of the present study do not definitely show the superiority of one method above the other in the assessment of dialysis adequacy. The fact that eKt/V values, but not spKt/V or URR values below the minimal target were related to mortality is likely to be more a reflection of calibration than of the parameter used. Interestingly, the analyses also showed a trend for better survival with URR and spKt/V values above target, suggesting that more dialysis dose is better.
A potential drawback of this study is the observation that a relatively small number of patients had a delivered eKt/V above the target level of 1.2, which could be attributed to the presence of residual renal function in a significant percentage of patients, and to the fact that the NECOSAD cohort was started before the publication of current guidelines. Indeed, taking residual renal function into account, weekly Kt/V could be considered adequate in the majority of patients. Additionally, we computed stdKt/V to compare the different dialysis schedules better on adequacy. A significant number of dialysis patients dialysed < 3 times a week because of residual renal function. stdKt/V is the designated parameter to interpret adequacy when schedules are irregular. Guidelines prescribe minimum stdKt/V of 2.1. About 67.5% of our patients met the target stdKt/V of 2.1, concluding adequate dialysis dose in the majority of the patients.
Moreover, it should be acknowledged that Kt/V only addresses one aspect of dialysis adequacy, which is the removal of small uraemic toxins, whereas other relevant factors such as removal of larger molecules and volume status are not addressed by this formula. Several observational studies have reported a reduced death risk in patients undergoing haemodialysis with high-flux membranes (Leypoldt JK AJKD 1999).
Concluding, the results of our study show that treatment minimums according to eKt/V are overestimated by cutoff values of spKt/V and URR in, respectively, 4 and 9% of patients. All adequacy parameters were related to mortality. The disagreement between the different formulas was related to low urea distribution volume and dialysis treatment time and, in case of URR, also to ultrafiltration volume. 
